Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
225.3 CHF | -1.50% | -58.28% | -58.28% |
07-16 | Aclaris Therapeutics Sells Olumiant Royalties, Milestone Payments From Eli Lilly | MT |
07-16 | Goldman Sachs Adjusts Price Target on Eli Lilly to $812 From $793 | MT |
- Stock Market
- Equities
- LLY Stock
- LEL Stock
- News Eli Lilly and Company